8-K: Atomera Reports First Quarter 2025 Results, Highlights Strategic Marketing Agreement

Atomera Incorporated announced its Q1 2025 financial results, including a net loss of $5.2 million, and highlighted a new strategic marketing agreement.

Summary

• Atomera Incorporated reported a net loss of $5.2 million, or $0.17 per share, for the first quarter of 2025.
• This compares to a net loss of $4.8 million, or $0.19 per share, for the first quarter of 2024.
• Adjusted EBITDA for Q1 2025 was a loss of $4.4 million, compared to a loss of $4.0 million in Q1 2024.
• The company had $24.1 million in cash, cash equivalents, and short-term investments as of March 31, 2025, down from $26.8 million at the end of 2024.
• The total number of shares outstanding was 30.7 million as of March 31, 2025.
• Atomera signed a strategic marketing agreement with a leading chip fabrication equipment vendor.
• They are expanding engagements at ST Microelectronics and RFSOI customers to new applications.
• Atomera built the first MST-enabled GaN devices at Sandia and began electrical testing.

Sentiment

Score: 5

Explanation: The report presents mixed signals. While the company highlights a strategic marketing agreement and expansion into new applications, the financial results show increased losses and a decrease in cash reserves. The forward-looking statements are cautiously optimistic, but tempered by risk factors.

Positives

• Atomera signed a strategic marketing agreement with a leading chip fabrication equipment vendor, which is expected to drive license revenues and increase the partner's capital equipment tool sales.
• The company is expanding its engagements with ST Microelectronics and RFSOI customers into new application areas.
• Atomera has built the first MST-enabled GaN devices at Sandia National Lab and initial electrical testing shows promising results.
• The Rapid Access Program at Sandia National Lab was renewed in April 2025.

Negatives

• Atomera incurred a net loss of $5.2 million in Q1 2025, which is higher than the $4.8 million loss in Q1 2024.
• Adjusted EBITDA also showed a larger loss of $4.4 million in Q1 2025 compared to $4.0 million in Q1 2024.
• The company's cash, cash equivalents, and short-term investments decreased from $26.8 million at the end of 2024 to $24.1 million as of March 31, 2025.

Risks

• Atomera is an early-stage enterprise and is subject to risks inherent in such a business.
• There is a risk that STMicroelectronics may not proceed with qualification of MST or take MST-enabled products to market.
• The company faces risks related to completing milestones in joint development agreements and reaching commercial distribution licenses.
• Atomera's ability to raise sufficient capital to pursue the development, licensing, and commercialization of MST technology is a risk.
• Protecting proprietary technology, trade secrets, and know-how is a key risk factor.

Future Outlook

The company believes its collaboration with a leading capital equipment company will strengthen deal execution and drive license revenues. Atomera anticipates growing opportunities for MST as they deepen relationships with lead customers and expand into new application areas.

Management Comments

• Scott Bibaud, President and CEO, stated that the collaboration with a leading capital equipment company will strengthen Atomera's deal execution and drive license revenues.
• Bibaud noted that the expansion to new application areas with ST and the fabless RF licensee demonstrates the growing opportunities for MST.

Industry Context

Atomera's focus on transistor enhancement technology and its strategic marketing agreement with a major semiconductor equipment maker align with the industry's ongoing efforts to improve performance and power efficiency in semiconductors. The company's MST technology is positioned as complementary to other nano-scaling technologies in the semiconductor industry roadmap.

Comparison to Industry Standards

• Atomera is focused on Mears Silicon Technology (MST), a quantum engineered material, to enhance transistor performance in the $600B semiconductor market.
• Competitors in the semiconductor materials and technology licensing space include companies like Applied Materials and Lam Research, though Atomera's MST technology offers a unique approach to transistor enhancement.
• The company's engagements with major semiconductor manufacturers like STMicroelectronics and its work with Sandia National Lab are indicative of its progress in validating and commercializing its technology.
• Atomera's focus on GaN devices and RF-SOI applications aligns with industry trends towards higher performance and power efficiency in these areas.

Stakeholder Impact

• Shareholders may be concerned about the increased net loss and decreased cash reserves.
• Employees may be encouraged by the strategic marketing agreement and expansion into new applications.
• Customers may benefit from the improved performance and power efficiency of MST-enabled semiconductors.
• The strategic marketing partner is expected to benefit from increased sales of capital equipment tools.

Next Steps

• Atomera will host a live video webinar on May 6, 2025, to discuss its financial results and recent progress.
• The company will continue to work with its strategic marketing partner to drive license revenues.
• Atomera will continue to expand engagements with ST Microelectronics and RFSOI customers.
• They will continue electrical testing of MST-enabled GaN devices at Sandia National Lab.

Key Dates

Keywords

MST, Atomera, semiconductor, licensing, GaN, financial results, strategic marketing agreement, STMicroelectronics, RFSOI, EBITDA